Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Hematologic Malignancies

NCT01760655 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University as lead sponsor.

NCT NCT01760655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01760655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two Step Approach to Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Hematologic Malignancies
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase
Phase 2
Overall status
Completed
Start date
December 24, 2012
Completion date
December 5, 2022
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia with flt3/itd mutation, acute myeloid leukemia with gene mutations, acute myeloid leukemia with inv(3) (q21.3;q26.2); gata2, mecom, acute myeloid leukemia with t(6;9) (p23;q34.1); dek-nup214, aplastic anemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, bcr-abl1 positive, chronic myelomonocytic leukemia, follicular lymphoma, hodgkin lymphoma, myelodysplastic syndrome, myelofibrosis, myeloid leukemia, non-hodgkin lymphoma, plasma cell myeloma, polycythemia vera, recurrent adult acute myeloid leukemia, recurrent childhood acute myeloid leukemia, refractory acute myeloid leukemia, secondary acute myeloid leukemia, therapy-related acute myeloid leukemia